Cairn Therapeutics, Inc. — Form D
Cairn Therapeutics, Inc. of TUCSON, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-14. The offering totals $7.3M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-09-14
- Form: D
- Accession: 0001882868-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $3.0M
- Remaining: $4.3M
- Investors: 27
- Date of first sale: 2021-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413356
Issuer
- Name: Cairn Therapeutics, Inc.
- CIK: 0001882868
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2255 E. AMBASSADOR COURT, TUCSON, AZ, 85719
- Phone: (913) 954-7879
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Dale Boger | Director | Tucson, AZ |
| Diarmuid Boran | Director | Tucson, AZ |
| W. Scott Evangelista | Director | Tucson, AZ |
| Roger Rajewski | Director | Tucson, AZ |
| Diarmuid Boran | Executive Officer | Tucson, AZ |
| George Vielhauer | Executive Officer | Tucson, AZ |
More